EnglishFrenchGermanSpainItalianDutchRussianPortugueseJapaneseKoreanArabicChinese Simplified
If you like the site do not forget to Subscribe to our mailing list

Enter your E-mail address:

Showing posts with label chemical. Show all posts
Showing posts with label chemical. Show all posts

Wednesday, December 30, 2015

Protein Acceleration Become Easy !

All living things require proteins, members of a vast family of molecules that nature "makes to order" according to the blueprints in DNA. Through the natural process of evolution, DNA mutations generate new or more effective proteins.
Humans have found so many alternative uses for these molecules - as foods, industrial enzymes, anti-cancer drugs - that scientists are eager to better understand how to engineer protein variants designed for specific uses.

Now Stanford engineers have invented a technique to dramatically accelerate protein evolution for this purpose. This technology, described in Nature Chemical Biology, allows researchers to test millions of variants of a given protein, choose the best for some task and determine the DNA sequence that creates this variant.

"Evolution, the survival of the fittest, takes place over a span of thousands of years, but we can now direct proteins to evolve in hours or days," said Jennifer Cochran, a professor of bioengineering who co-authored the paper with Thomas Baer, director of the Stanford Photonics Research Center.
 "This is a practical, versatile system with broad applications that researchers will find easy to use," Baer said. 

By combining Cochran's protein engineering knowhow with Baer's expertise in laser-based instrumentation, the team created a tool that can test millions of protein variants in a matter of hours.
"The demonstrations are impressive and I look forward to seeing this technology more widely adopted," said Frances Arnold, a professor of chemical engineering at Caltech who was not affiliated with the study. Making a million mutants The researchers call their tool µSCALE, or Single Cell Analysis and Laser Extraction.



The "µ" stands for the microcapillary glass slide that holds the protein samples. The slide is roughly the size and thickness of a penny, yet in that space a million capillary tubes are arrayed like straws, open on the top and bottom.

1 / 3 The microcapillary glass slide that holds the protein samples is roughly the size and thickness of a penny, yet in that space a million capillary tubes are arrayed like straws. Credit: Cochran Lab, Stanford The power of µSCALE is how it enables researchers to build upon current biochemical techniques to run a million protein experiments simultaneously, then extract and further analyze the most promising results.

The researchers first employ a process termed "mutagenesis" to create random variations in a specific gene. These mutations are inserted into batches of yeast or bacterial cells, which express the altered gene and produce millions of random protein variants. A µSCALE user mixes millions of tiny opaque glass beads into a sample containing millions of yeast or bacteria and spreads the mixture on a microcapillary slide.

Tiny amounts of fluid trickle into each tube, carrying individual cells. Surface tension traps the liquid and the cell in each capillary. The slide bearing these million yeast or bacteria, and the protein variants they produce, is inserted into the µSCALE device. A software-controlled microscope peers into each capillary and takes images of the biochemical reaction occurring therein. Once a µSCALE user identifies a capillary of interest, the researcher can direct the laser to extract the contents of that tube without disrupting its neighbors, using an ingenious method devised by Baer. "The beads are what enable extraction," Baer said.

"The laser supplies energy to move the beads, which breaks the surface tension and releases the sample from the capillary." Thus µSCALE empties the contents of a single capillary onto a collector plate, where the DNA of the isolated cell can be sequenced and the gene variant responsible for the protein of interest can be identified.


More information: http://phys.org/news/2015-12-protein-evolution.html

------------------------- *Leave a comments, questions or even a suggestions below this post. Your expressions are always welcomed.

Tuesday, December 18, 2012

World's smallest reaction chamber Done!!!


Scientists from New Zealand, Austria and the UK have created the world's smallest reaction chamber, with a mixing volume that can be measured in femtoliters (million billionths of a liter).








Using this minuscule reaction chamber, lead researcher Peter Derrick, professor of chemical physics and physical chemistry and head of the Institute of Fundamental Sciences at Massey University in New Zealand, plans to study the kind of speedy, nanoscale biochemical reactions that take place inside individual cells. This work appears in the latest issue of the European Journal of Mass Spectrometry.

The reaction chamber actually consists of nothing more than a tiny spray of liquid. It is produced by a technique known as electrospray ionization, in which a liquid is converted into lots of charged droplets by exposing it to a high voltage as it exits the nozzle of a thin capillary.

Like water being sprayed out of a hose, these charged droplets form a cone shape, known as a Taylor cone, as they are emitted from the nozzle. Because the electrospray process transforms any chemical entities within the liquid into ions, it is a commonly used technique for ionizing a liquid sample prior to analysis by mass spectrometry.

In conventional electrospray ionization, the charged droplets are emitted from a single nozzle and form a single Taylor cone. Derrick realised that emitting charged droplets with different chemical compositions from two separate but adjoining nozzles would cause their respective Taylor cones to merge, potentially allowing the chemical entities in those droplets to react together.

By making the nozzles small enough, such that they produce Taylor cones with femtolitre volumes, and linking them to a mass spectrometer, this set-up could be used to study the kind of speedy, nanoscale biochemical reactions that take place within cells. "The idea was that the entities could be introduced separately through the two channels lying side-by-side into this extremely small volume," explains Derrick.

To test this approach, he and his colleagues fabricated a metal-coated dual-channel electrospray emitter, in which a single circular capillary, just 4.5 μm in diameter, is divided into two semi-circular channels. After first spraying different colour dye molecules from each channel and showing that the resultant Taylor cones merge together, the scientists sprayed the antibiotic vancyomycin from one channel and a version of the peptide it binds to from the other.

As expected, the two molecules bound to each other within the merged, femtolitre-size Taylor cone, with the whole reaction process taking just a few tens of microseconds. The resultant molecular complex formed by vancyomycin and the peptide could clearly be detected by the mass spectrometer.

"We showed that a device that works as hoped can be fabricated and that biochemical reactions do occur within the very small volume," says Derrick.

As well as offering a novel way to study biochemical reactions, this approach could provide a whole new way to conduct electrospray ionization. "This could become the standard method of doing electrospray," says Derrick, "because none of the myriad beneficial capabilities of present-day electrospray are lost through using just one channel for the sample. The other channel could then be used for compounds that can probe the chemical properties of the sample."

Note: This story has been adapted from a news release issued by the IM Publications LLP

------------------------- *Leave a comments, questions or even a suggestions below this post. Your expressions are always welcomed.

Thursday, August 5, 2010

Chemical link to testicular cancer

Teething baby
Scientists hope to prove whether common environmental chemicals, such as those used to make plastics, are to blame for rising testicular cancer rates.
Experts suspect that exposure while in the womb might explain why the rate of this cancer has doubled in 35 years.
The Edinburgh team told Human Reproduction such a study was only now possible because they had made a model to study the disease in development.
They will use mice harbouring human cells to test the theory.
Testicular cancer occurs in young men, but doctors have known for some years that the abnormal changes that lead to testicular cancer happen in the first few months that the foetus is growing.

Start Quote

We need to know for sure if these compounds are harmful or not. The hope is that our studies can resolve this one way or another”
But because these changes occur during early pregnancy, when there is no means of studying the foetal testes, doctors do not know how and why these changes occur.
Researchers are fairly certain there must be an environmental cause because the rate of the cancer has increased so rapidly.
According to Professor Richard Sharpe, of the Medical Research Council's Human Reproductive Sciences Unit, one theory is that the changes are caused by pregnant women being exposed to environmental chemicals such as phthalates, which are used in many different household items, including plastic furniture and packaging.
But because the cancers only develop 20-40 years after the patient is born, it has been hard for doctors to discover what happened in foetal development to cause this to happen, especially when trying to establish if their mothers were exposed to phthalates or other environmental chemicals to establish a causal relationship.
Mouse model
Now the MRC researchers have developed a model in which early human foetal testis development can be studied and manipulated experimentally to establish once and for all if exposure to environmental chemicals is a likely culprit.

Related stories

Prof Sharpe's team has grafted testis tissue from aborted foetuses under the skin of mice. The germ cells in the testes are at the critical stage when any faults in their development can result in changes which make them pre-cancerous.
The researchers will expose the mice to phthalates or other environmental chemicals to see if this induces changes in the foetal germ cells that would predispose them to develop into a cancer.
Prof Sharpe said: "We are choosing to study phthalates first for several reasons, because we know that in the test-tube they can affect foetal human germ cells. They are also the most ubiquitous of environmental chemicals. We are all exposed to them."
Phthalates are used to make plastic flexible, and so can be found in carpets, wall boards, car upholstery and fittings and certain cosmetics and pharmaceutical drugs.
However, Prof Sharpe said that there was uncertainty about whether phthalate effects on the foetus in animal models were relevant to humans.
He said: "This is one of the critical unresolved questions as to whether phthalates pose a risk to human health or not.
"It's a huge industry. These compounds are literally part of the fabric of our modern society so they cannot easily be banned or removed without having widespread effects on everyday life. We need to know for sure if these compounds are harmful or not. The hope is that our studies can resolve this one way or another."
The researchers say that if phthalates do cause effects on human foetal germ cells they could know within a year. If the chemicals are not responsible it could take much longer to conclusively disprove any link.